What is TARGET? The Therapeutically Applicable Research to Generate Effective Treatments (TARGET) Initiative seeks to harness the power of modern genomics technologies to rapidly identify valid therapeutic targets in childhood cancers.
Read more
Don't miss TARGET at the American Association for Cancer Research (AACR) Annual Meeting 2012!
TARGET session details
Date: Sunday, April 1, 2012
Time: 3:30pm - 5:30pm
Location: Room W194
Cancer Genomics for Pediatric Cancers
October 11, 2011
Javed Khan, M.D., a molecular biologist at the National Cancer Institute (NCI), discusses the approach and implications of cancer genome programs such as TARGET in this video.
Key pathways are frequently mutated in high risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group
Blood
June 16, 2011
In the largest pediatric cancer genome sequencing effort reported to date, TARGET ALL researchers sequenced 120 candidate genes in 187 high-risk childhood B-precursor acute lymphoblastic leukemias (HR B-ALL). Read more.
Learn more about TARGET through these multimedia resources:
Get the most current data from TARGET's projects. Comprehensive access to TARGET datasets, including genomic characterization, full clinical information, and sequencing files, is available through the TARGET Data Matrix. Visit the TARGET Data Portal for more information.
Acute Lymphoblastic Leukemia (ALL)
Acute Myeloid Leukemia (AML)
Neuroblastoma
Osteosarcoma
Wilms Tumor
Stay Connected. Sign up for cancer genomics updates
The collaborative network of researchers is led by:
Office of Cancer Genomics (NCI)
Cancer Therapy Evaluation Program (NCI)
Children's Oncology Group
Data Coordinating Center (NCI)
Map of the TARGET collaborative network
HHS
NIH
USA
